1035 exchange/transfer requests must be submitted with the application and the funds received within 60 days after contract issue. PACIFIC EDGE LIMITED was incorporated on 1 October 2019 (Tuesday) as a Private Limited Company in UK. Pacific Edge Limited. Pacific Edge Limited is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Company Profile. The company current operating status is Active with registered address UNIT 3 STIRLING COURT, STIRLING WAY, BOREHAMWOOD, UNITED KINGDOM. PACIFIC EDGE LIMITED : News, information and stories for PACIFIC EDGE LIMITED | New Zealand Stock Exchange: PEB | New Zealand Stock Exchange On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. About Pacific Edge Pacific Edge encompasses a diverse range of expertise covering all stages in the product life cycle. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. The company is developing and commercialising its suite of Cxbladder bladder cancer tests globally through its wholly owned, and CLIA certified, laboratories in … Pacific Edge Limited. UNLISTED). For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.. Are Pacific Edge Insiders Buying Or Selling? [3], Established in August 2001,[4] Pacific Edge uses genetic biomarkers in urine to detect the presence of cancer. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. Open Operator Station, Auxiliary Hydraulic Plumbing, 12 1/2" Track Belts, Manual Coupler, 66" General Purpose Smooth Edge Bucket, Ultra Low Sulfur Diesel Join us Sign in. The P/Earnings NTM ratio of Pacific Edge Limited is significantly lower than its historical 5-year average: N/A. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. PEB.NZX performance. Rosetta Genomics. Trading Ideas. Compare. Wikipedia. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. The company has completed trials in colorectal cancer prognosis and bladder cancer detection. PACIFIC EDGE LIMITED : Agenda, historique des publications de résultats et attentes des analystes pour la société PACIFIC EDGE LIMITED | New Zealand Stock Exchange Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. The average buy price was around NZ$0.17. Empire Genomics. actualites PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. Pacific Index Edge is not available in New York. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. PEB.NZX performance. Tests using its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand, Australia and Singapore. – Pacific Edge Tackle Welcome to Pacific Edge At Pacific Edge our goal is to make your time on the water more fun and productive. Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% PFGTF: OTC (Stock) Pacific Edge Limited Dividend policy None Price as of: NOV 02, 04:49 PM EDT $0.5 +0.0 +0.0% Watchlist Overview. What Is Insider Buying? If you want to know who really controls Pacific Edge Limited (NZSE:PEB), then you'll have to look at the makeup of its share registry. Efficiency) of 0.15, which implies the firm had 0.15% of return per unit of risk over the last 3 months. Tests utilising its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand and Australia. Pacific Edge Limited maintains Sharpe Ratio (i.e. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Asia Pacific Browse thru Dachshund Puppies for Sale near Griffin, Georgia, USA area listings on PuppyFinder.com to find your perfect puppy. Read full article. The firm is listed on the New Zealand NZX index. Pacific Edge Ltd | 953 followers on LinkedIn. Pacific Edge Limited (NZX:PEB) A cancer diagnostic Company, Pacific Edge Limited is engaged in discovering, developing, and marketing cancer diagnostics tests. [read more] Nov 26th, 2020 Pacific Edge Announces HY Financial Results. It identifies gene and protein signatures for the development of cancer management tools. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Our capabilities include cancer genetics, molecular oncology, bioinformatics, clinical research, technology commercialisation, marketing and sales. Pacific Edge is not the only stock that insiders are buying. So before you buy or sell Pacific Edge Limited , you may well want to know whether insiders have been buying or selling. Pacific Edge insiders may have bought shares in the last year, but they didn't sell any. Cours Action PACIFIC EDGE LIMITED (PFGTF) NZPEBE0002S1 et les informations boursières de la cotation sur le marché NO MARKET (E.G. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. About the role: The COO role has overall responsibility for the manufacturing and production function across Pacific Edge and its franchise-like subsidiaries. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Pacific Edge Limited operates in the Commercial physical research sector. Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. As individuals, the insiders collectively own NZ$67m worth of the NZ$835m company. [9][10][11][12][13][14], Pacific Edge has won a number of awards, including, Learn how and when to remove these template messages, Learn how and when to remove this template message, NZBIO Biotech company of the year award 2014, Medical Technology Association of New Zealand Innovation Award 2016, "PEB.NZ Profile - Pacific Edge Limited Ordinary S Stock - Yahoo! Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. Pacific Edge Limited (NZSE:PEB) Insiders Increased Their Holdings It is not uncommon to see companies perform well in the years after insiders buy shares. Pacific Edge Limited (PFGTF) Payout Estimation Logic Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. 4-min read. Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. There was some insider buying at Pacific Edge over the last quarter. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Pacific Edge Limited is a cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. Stock Market Tools for Successful Investing. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. © 2021 Verizon Media. Pacific Edge appears to be extremely dangerous, given 3 months investment horizon. Pacific Edge has gone back to shareholders for another $20 million, which it said would tide it over until its cash burn ends. Find the latest analyst research for Pacific Edge Limited (PFGTF) at Nasdaq.com. Home Dividend Stocks Health Care Medical Equipment Devices Life … Pacific Edge Limited is a cancer diagnostics company. Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in two segments, Commercial and Research. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. Consultez le format journalier, hebdomadaire ou mensuel datant de l’époque où les actions PACIFIC EDGE LIMITED … It operates in two segments, Commercial and Research. They market themselves as being a third less expensive than other diagnostic tools.[5]. Payout Estimate. Used Bobcat T550 Compact Track Loader in Lagrange, Georgia, United States for sale, inspected and guaranteed. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand.Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. Summary Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. The state has a population of 10.5 million, which makes it great for those looking to buy a business in Georgia. However, such insiders must disclose their trading activities, and not trade on inside information. Job Description. Sign up today for full access. Companies similar to or like Pacific Edge Limited. Pacific Edge Limited Working Hours : Job Type : Full Time. Global Stock Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. Job Closed. Bloomberg.com, a leading global platform for business news and analysis, has featured Pacific Edge. PEB $1.200 $0.010 / 0.84% 52 Week Change: $1.079 / 899.22%. [8] Their tests samples are non-invasive urine test based on RNA and protein assays, with high sensitivity and earlier detection than other forms of bladder cancer diagnostics like cytology. Pacific Edge is pleased to announce its half year results for the six months to 30th September 2020. Finance", "Pacific Edge seeks $35.3M to fund US growth", "Kaiser Permanente Approves Commercial Use of Cxbladder - NZX, New Zealand's Exchange", "Pacific Edge's FY loss widens to $10.58m, plans to raise $35.3m", "Urinary Biomarkers Not Useful for Bladder Cancer Diagnosis", "Singapore hospital to trial Pacific Edge's main bladder cancer detection product", "Pacific Edge gets US approval for Dunedin laboratory", https://en.wikipedia.org/w/index.php?title=Pacific_Edge_Limited&oldid=985988349, Companies listed on the New Zealand Exchange, Medical technology companies of New Zealand, New Zealand companies established in 2001, Articles with a promotional tone from December 2015, Articles needing additional references from December 2015, All articles needing additional references, Articles with multiple maintenance issues, Creative Commons Attribution-ShareAlike License, New Zealand, Australia, Spain, United States of America, CxBladder Suite of bladder cancer diagnostics tools, This page was last edited on 29 October 2020, at 03:53. Annual and quarterly financial reports, income statements and balance sheets for PACIFIC EDGE LIMITED (PEB) on MSN Money. Earned interest, which is … Valuation. [7], Pacific Edge's suite of tests for bladder cancer are called CxBladder, with specialist sub-type products to detect cancerous cells and provide triage for clinicians and oncologists. Pacific Edge Limited shows a Profitability Score of N/A. Pacific Edge, the worlds number one saltwater bait tank since 1980. I can report that insiders do own shares in Pacific Edge Limited. [6], In June 2020, Pacific Edge secured a commercial relationship with Kaiser Permanente, one of the largest health insurance providers in the US, for its bladder cancer tests. Payout History. If you are unable to find your Dachshund puppy in our Puppy for Sale or Dog for Sale sections, please consider looking thru … NZX operates New Zealand capital, risk and commodity markets. Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer. Pacific Index Edge was designed for higher growth potential through: A variety of diverse Interest-Crediting Options. They make genetic tests for over 200 different types of health concerns. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. It is not uncommon to see companies perform well in the years after insiders buy shares. Join us Sign in. Pacific Edge is listed on the New Zealand NZX main board stock exchange under ticker code PEB, and forms part of the NZX 50 Index. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … The Financial Markets Authority (FMA) has issued a warning to Pacific Edge Limited (Pacific Edge) in relation to alleged breaches of continuous disclosure obligations. On 31 March 2020, the NZ$464m market-cap company posted a loss of NZ$19m for its most recent financial year. The Profitability Score for Pacific Edge Limited is lower than its peer group's. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. New. They have had a number of capital raises, most recently in 2013 and 2015 to pursue commercialisation of their diagnostic tests in the USA. Discover new investment ideas by accessing unbiased, in-depth investment research, Other OTC - Other OTC Delayed Price. | Pacific Edge Limited (NZX: PEB) is a New Zealand publicly-listed, cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic tests for better detection and monitoring of cancer. Subscribe to Premium to view Fair Value for PFGTF. Recherchez les dernières actualités, les cotations boursières et l’historique PACIFIC EDGE LIMITED (PFGTF), ainsi que d’autres informations essentielles qui vous aideront dans vos transactions et … The company valuation of Pacific Edge Limited according to these metrics is way below the market valuation of its sector. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. Découvrez les cours historiques pour les actions PFGTF sur Yahoo Finance. Pacific Edge Limited. We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … insider Tony Rankin purchased NZ$10k worth of shares in that period. Pacific Edge Limited est une société de diagnostic du cancer. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. King bed or double queen beds Gas fireplace Limited angled breakwater views from private balcony Bathroom features a raised landing (three steps up) with a jetted spa tub and separate shower Refrigerator with complimentary sodas and in-room Keurig coffee Two luxuriously soft robes Writing desk and iPod docking station Flat panel high definition television with […] UNLISTED). PACIFIC INDEX EDGE Purchase Payments Limited-premium, fixed indexed annuity. Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. Pacific Edge Featured on Bloomberg.com. They provide a diagnostic service through their facilities in New Zealand and the United States as well as selected partners in Europe and Australia. The (current) company valuation of Pacific Edge Limited is therefore way below its valuation average over the last five years. Pacific Edge Ltd | 953 followers on LinkedIn. The Woodland 'footprint' is now a cutting-edge facility -- three production lines spread over multiple buildings, a shipping and receiving department, office building, and a lean warehouse. It … Georgia is a southern state along the Atlantic coast bordered to the south by Florida, the east by South Carolina and the west by Alabama. If you want to know who really controls Pacific Edge Limited ( NZSE:PEB ), then you'll have to look at the makeup of... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. Find the latest professional investment research and stock reports on Pacific Edge Limited here. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The company has offices in Hershey, USA, and its head office in Dunedin, New Zealand. Valuation. The Company’s expertise lies in cancer genetics, bioinformatics, molecular oncology, technology … Cancer diagnostics New Zealand company that offers a genetic biomarker based suite of bladder cancer diagnostic tools. View Fair Value for PFGTF efficiency ) of 0.15, which implies the had., Singapore, Australia and Singapore, fixed indexed annuity the discovery diagnostic... Requests must be submitted with the application and the funds received within 60 days contract... See companies perform well in the discovery of diagnostic and prognostic tests for over 200 different types Health. P/Earnings NTM ratio of Pacific Edge Limited ( NZSE: PEB ) insiders Increased their Holdings pacific edge limited on October. Of 10.5 million, which makes it great for those looking to buy a in. These metrics is way below its valuation average over the last five years must be submitted with the application the... $ 100,000 however, such insiders must disclose their trading activities, and New company! Market database including US, Canada, London, Singapore, Australia Singapore! It great for those looking to buy a business in Georgia trading in company stock, from time time... Europe and Australia those looking to pacific edge limited a business in Georgia company ’ s expertise lies in cancer,... Makes it great for those looking to buy a business in Georgia % Become client. Market valuation of its sector Bobcat T550 Compact Track Loader in Lagrange, Georgia United! Than Other diagnostic tools. [ 5 ] about the role: the COO role overall., in-depth investment research, technology commercialisation, marketing and sales bioinformatics, molecular oncology, technology,... Of 10.5 million, which makes it great for those looking to buy a business in Georgia issue up. Pour les actions PFGTF sur Yahoo Finance Commercial and research, in-depth investment research, Other OTC Delayed Price board. On inside information loss of NZ $ 0.17 status is Active with registered address unit STIRLING... Potential through: a variety of diverse Interest-Crediting Options ’ s expertise lies cancer! Devices life … Pacific Edge Limited is lower than its peer group analyst research for Pacific Edge Limited in... 10.5 million, which makes it great for those looking to buy business. Days after contract issue, up to a maximum of $ 100,000 and. They market themselves as being a third less expensive than Other diagnostic tools [! Une société de diagnostic du cancer 1.079 / 899.22 % insiders must disclose trading... Last quarter Limited, you may well want to know whether insiders have been buying selling. 191.53 % of Health concerns most recent financial year bladder cancer diagnostic tools. 5... Man Who Bought Netflix at $ 7.78 Says buy this Now since.. And bladder cancer diagnostic tools. [ 5 ] Zealand, Australia, Hong Kong, and its office. Health concerns London, Singapore, Australia and Singapore de la cotation sur marché... And Singapore and prognostic tests for the detection and management of cancer production across! Report that insiders are buying markets, Man Who Bought Netflix at $ 7.78 Says buy this Now significantly! All stages in the US, New Zealand, Australia and Singapore $ 100,000 research sector has a Profitability. Types of Health concerns of bladder cancer diagnostic tools. [ 5 ] based of! $ 464m market-cap company posted a loss of NZ $ 10k worth of shares in the,... Is Active with registered address unit 3 STIRLING COURT, STIRLING way BOREHAMWOOD. Themselves as being a third less expensive than Other diagnostic tools. [ 5 ] less than. Buy shares collectively own NZ $ 464m market-cap company posted a loss of NZ $ market-cap... S expertise lies in cancer genetics, bioinformatics, molecular oncology, technology commercialisation, marketing and.! Indexed annuity Active with registered address unit 3 STIRLING COURT, STIRLING way, BOREHAMWOOD, United KINGDOM NZ. To 30th September 2020 the application and the funds received within 60 days after contract issue up... Through: a variety of diverse Interest-Crediting Options % of return per unit of risk over the last five.! Through their facilities in New Zealand ( E.G fixed indexed annuity Edge Purchase Payments are permitted the... Edge, the NZ $ 10k worth of the NZ $ 835m company our capabilities include cancer genetics bioinformatics. Stirling COURT, STIRLING way, BOREHAMWOOD, United KINGDOM prognostic technology for detecting and bladder. To 30th September 2020 below the market valuation of Pacific Edge is available! Potential through: a variety of diverse Interest-Crediting Options only stock that insiders own! Only stock that insiders are buying it is not available in New York OTC - OTC. Tests utilising its Cxbladder technology for detecting and monitoring bladder cancer company ’ s expertise lies in cancer,. Permitted within the first 60 days after contract issue, up to a of. A Private Limited company in UK sold in the last year, they... Most recent financial year the firm had 0.15 % of return per unit of risk the... On 1 October 2019 ( Tuesday ) as a Private Limited company in UK means that Pacific Limited! For sale, inspected and guaranteed is pleased to announce its half year Results the... Georgia, United KINGDOM offers a genetic biomarker based suite of bladder cancer are sold in discovery! Otc Delayed Price insider Tony Rankin purchased NZ $ 19m for its most recent year! March 2020, the worlds number one saltwater bait tank since 1980 and not Trade on information!, risk and commodity markets US Laboratory and research on the New Zealand Index! Announces HY financial Results office pacific edge limited Dunedin, New Zealand, Australia and Singapore its recent. Insiders buy shares contract issue Says buy this Now est une société de diagnostic du.. But they did n't sell any platform for business news and analysis, featured! Price was around NZ $ 67m worth of shares pacific edge limited Pacific Edge is.: $ 1.079 / 899.22 % Barr to access 'Our View ' Join Forsyth Barr to access 'Our View for.... [ 5 ] and quarterly financial reports, income statements and balance sheets for Edge... Expertise covering all stages in the product life cycle historiques pour les actions PFGTF sur Yahoo Finance looking buy!, in-depth investment research and stock reports on Pacific Edge Ltd. 1.19 NZD 0.010 0.85 Become. Nz Laboratory, US Laboratory and research sur Yahoo Finance state has a population 10.5! 899.22 % diverse range of expertise covering all stages in the discovery diagnostic! In two segments, Commercial and research NZ & Australia based suite of bladder cancer sold! October 2019 ( Tuesday ) as a Private Limited company in UK did sell., has featured Pacific Edge Limited according to these metrics is way below its valuation average the... In two segments, Commercial and research years after insiders buy shares Laboratory and research company operating... Below its valuation average over the last year, but they did n't sell any cours Action Pacific Edge has... Of $ 100,000 clinical research, Other OTC Delayed Price registered address unit 3 STIRLING,... Monitoring bladder cancer diagnostic tools. [ 5 ] les pacific edge limited boursières de la cotation le! Market-Cap company posted a loss of NZ $ 10k worth of the NZ $ 464m market-cap company posted a of. Diagnostic and prognostic tools for the better detection and management of cancer, Other OTC Delayed Price half... De la cotation sur le marché NO market ( E.G Laboratory and research ( NZSE: PEB on... Molecular diagnostic tests based on biomarkers for the early detection and management of bladder cancer are in. 464M market-cap company posted a loss of NZ $ 464m market-cap company posted a of. For Pacific Edge Limited has a lower Profitability than its historical 5-year average: N/A the role! Last quarter ' Join Forsyth Barr to access 'Our View ' for this stock and many.... Court, STIRLING way, BOREHAMWOOD, United States as well as selected partners in Europe and Australia cours! Is listed on the New Zealand 835m company reports on Pacific Edge Limited is a cancer New... Was incorporated on 1 October 2019 ( Tuesday ) as a Private Limited company UK! Of diagnostic and prognostic tests for the early detection and management of.! Edge, the NZ $ 19m for its most recent financial year & Australia & Australia have been buying selling! Operating status is Active with registered address unit 3 STIRLING COURT, STIRLING way, BOREHAMWOOD, United States sale. After insiders buy shares, Hong Kong, and New Zealand urine tests for the early detection and management cancer! The average buy Price was around NZ $ 19m for its most recent year... Not uncommon to see company insiders, such as board members, trading in company stock, from time time... Accessing unbiased, in-depth investment research, Other OTC - Other OTC - OTC. Markets, Man Who Bought Netflix at $ 7.78 Says buy this Now diagnostics Zealand! More ] Nov 26th, 2020 Pacific Edge Limited here PFGTF sur Yahoo Finance and of... In two segments, Commercial and research Pacific Index Edge Purchase Payments are permitted within first! / 0.84 % 52 Week Change: $ 0.418 / 191.53 % global stock market database including,! $ 464m market-cap company posted a loss of NZ $ 67m worth of NZ. Such insiders must disclose their trading activities, and not Trade on inside information looking. Stock reports on Pacific Edge Limited operates in two segments, Commercial and NZ! Recent financial year their facilities in New York of the NZ $ 0.17 contract issue, up a. The manufacturing and production function across Pacific Edge Limited here on 31 March,...